Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 205


Radiotherapy for Pituitary and Hypothalamic Tumours.

Welsh L, Ajithkumar T, Brada M.

In: De Groot LJ, Beck-Peccoz P, Chrousos G, Dungan K, Grossman A, Hershman JM, Koch C, McLachlan R, New M, Rebar R, Singer F, Vinik A, Weickert MO, editors. Endotext [Internet]. South Dartmouth (MA):, Inc.; 2000-.
2013 Jan 3.


Glioblastoma adaptation traced through decline of an IDH1 clonal driver and macro-evolution of a double-minute chromosome.

Favero F, McGranahan N, Salm M, Birkbak NJ, Sanborn JZ, Benz SC, Becq J, Peden JF, Kingsbury Z, Grocok RJ, Humphray S, Bentley D, Spencer-Dene B, Gutteridge A, Brada M, Roger S, Dietrich PY, Forshew T, Gerlinger M, Rowan A, Stamp G, Eklund AC, Szallasi Z, Swanton C.

Ann Oncol. 2015 May;26(5):880-7. doi: 10.1093/annonc/mdv127. Epub 2015 Mar 2.


SABR in NSCLC--the beginning of the end or the end of the beginning?

Brada M, Pope A, Baumann M.

Radiother Oncol. 2015 Feb;114(2):135-7. doi: 10.1016/j.radonc.2015.01.012. Epub 2015 Feb 6. No abstract available.


New developments in intracranial stereotactic radiotherapy for metastases.

Pinkham MB, Whitfield GA, Brada M.

Clin Oncol (R Coll Radiol). 2015 May;27(5):316-23. doi: 10.1016/j.clon.2015.01.007. Epub 2015 Feb 7.


Algal biomass analysis by laser-based analytical techniques--a review.

Pořízka P, Prochazková P, Prochazka D, Sládková L, Novotný J, Petrilak M, Brada M, Samek O, Pilát Z, Zemánek P, Adam V, Kizek R, Novotný K, Kaiser J.

Sensors (Basel). 2014 Sep 23;14(9):17725-52. doi: 10.3390/s140917725. Review.


Prognostic and predictive markers in recurrent high grade glioma; results from the BR12 randomised trial.

Collins VP, Ichimura K, Di Y, Pearson D, Chan R, Thompson LC, Gabe R, Brada M, Stenning SP; BR12 Collaborators.

Acta Neuropathol Commun. 2014 Jun 20;2:68. doi: 10.1186/2051-5960-2-68.


Is current technology improving outcomes with radiation therapy for gliomas?

Brada M, Haylock B.

Am Soc Clin Oncol Educ Book. 2014:e89-94. doi: 10.14694/EdBook_AM.2014.34.e89.


High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Stupp R, Brada M, van den Bent MJ, Tonn JC, Pentheroudakis G; ESMO Guidelines Working Group.

Ann Oncol. 2014 Sep;25 Suppl 3:iii93-101. doi: 10.1093/annonc/mdu050. Epub 2014 Apr 29. No abstract available.


Comparison of setup accuracy and intrafraction motion using stereotactic frame versus 3-point thermoplastic mask-based immobilization for fractionated cranial image guided radiation therapy.

Rosenfelder NA, Corsini L, McNair H, Pennert K, Aitken A, Lamb CM, Long M, Clarke E, Murcia M, Schick U, Burke K, Ashley S, Khoo V, Brada M.

Pract Radiat Oncol. 2013 Jul-Sep;3(3):171-9. doi: 10.1016/j.prro.2012.06.004. Epub 2012 Jul 19.


The legend of cytomegalovirus and glioblastoma lives on.

Weller M, Soffietti R, Brada M.

Neuro Oncol. 2014 Jan;16(1):166. doi: 10.1093/neuonc/not204. Epub 2013 Dec 4. No abstract available.


Cone beam CT verification for active breathing control (ABC)-gated radiotherapy for lung cancer.

Yeoh KW, McNair HA, McDonald F, Hawkins M, Hansen VN, Ramos M, Fragkandrea I, Bothwell S, Herbert T, Taylor H, Helyer S, Ashley S, Brada M.

Acta Oncol. 2014 May;53(5):716-9. doi: 10.3109/0284186X.2013.861610. Epub 2013 Nov 25. No abstract available.


Long-term efficacy of fractionated radiotherapy for benign meningiomas.

Soldà F, Wharram B, De Ieso PB, Bonner J, Ashley S, Brada M.

Radiother Oncol. 2013 Nov;109(2):330-4. doi: 10.1016/j.radonc.2013.10.006. Epub 2013 Oct 31.


Stereotactic radiotherapy (SABR) for the treatment of primary non-small cell lung cancer; systematic review and comparison with a surgical cohort.

Soldà F, Lodge M, Ashley S, Whitington A, Goldstraw P, Brada M.

Radiother Oncol. 2013 Oct;109(1):1-7. doi: 10.1016/j.radonc.2013.09.006. Epub 2013 Oct 12. Review.


Position statement on ethics, equipoise and research on charged particle radiation therapy.

Sheehan M, Timlin C, Peach K, Binik A, Puthenparampil W, Lodge M, Kehoe S, Brada M, Burnet N, Clarke S, Crellin A, Dunn M, Fossati P, Harris S, Hocken M, Hope T, Ives J, Kamada T, London AJ, Miller R, Parker M, Pijls-Johannesma M, Savulescu J, Short S, Skene L, Tsujii H, Tuan J, Weijer C.

J Med Ethics. 2014 Aug;40(8):572-5. doi: 10.1136/medethics-2012-101290. Epub 2013 Sep 17.


Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.

Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, Ohman P, Frederich R, Wiviott SD, Hoffman EB, Cavender MA, Udell JA, Desai NR, Mosenzon O, McGuire DK, Ray KK, Leiter LA, Raz I; SAVOR-TIMI 53 Steering Committee and Investigators.

N Engl J Med. 2013 Oct 3;369(14):1317-26. doi: 10.1056/NEJMoa1307684. Epub 2013 Sep 2.


The impact of brain metastases on the clinical service in a cancer center.

Clarke E, Brock J, Soldà F, Gupta S, Brada M.

J Palliat Med. 2013 Aug;16(8):836-7. doi: 10.1089/jpm.2013.0194. Epub 2013 Jun 14. No abstract available.


Clinical controversies: proton radiation therapy for brain and skull base tumors.

Combs SE, Laperriere N, Brada M.

Semin Radiat Oncol. 2013 Apr;23(2):120-6. doi: 10.1016/j.semradonc.2012.11.011. Review.


Proton therapy: the present and the future.

Brada M, Bortfeld T.

Semin Radiat Oncol. 2013 Apr;23(2):75-6. doi: 10.1016/j.semradonc.2012.11.001. No abstract available.


Radiotherapy for benign brain tumours coming of age; example of vestibular schwannoma.

Brada M.

Radiother Oncol. 2013 Feb;106(2):157-60. doi: 10.1016/j.radonc.2013.01.009. Epub 2013 Feb 22. No abstract available.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk